practice emq summer 2015 Flashcards
This would be appropriate management for a patient with moderate persistent asthma at Step 3 of the asthma management ladder.
A.
Anti-histamine
B.
Anti-IgE therapy
C.
Beta blocker
D.
Check inhaler technique
E.
Epipen: Adrenaline 0.3mg IM
F.
High dose inhaled corticosteroid (ICS)
G.
High dose inhaled corticosteroid (ICS) + long-acting beta agonist (LABA) + leukotriene antagonist
H.
High dose inhaled corticosteroid (ICS) + long-acting beta agonist (LABA)
I.
High flow oxygen and Nebulised Salbutamol
J.
Low dose inhaled corticosteroid (ICS)
K.
Magnesium IV
L.
Medium dose inhaled corticosteroid (ICS) + long-acting beta agonist (LABA)
M.
Salbutamol metered dose inhaler (MDI)
N.
Short acting beta agonist (SABA) and leukotriene antagonist
A patient is taking a Salbutamol easibreathe inhaler and using it around five times a week. What additions would you make to their medication?
A.
Anti-histamine
B.
Anti-IgE therapy
C.
Beta blocker
D.
Check inhaler technique
E.
Epipen: Adrenaline 0.3mg IM
F.
High dose inhaled corticosteroid (ICS)
G.
High dose inhaled corticosteroid (ICS) + long-acting beta agonist (LABA) + leukotriene antagonist
H.
High dose inhaled corticosteroid (ICS) + long-acting beta agonist (LABA)
I.
High flow oxygen and Nebulised Salbutamol
J.
Low dose inhaled corticosteroid (ICS)
K.
Magnesium IV
L.
Medium dose inhaled corticosteroid (ICS) + long-acting beta agonist (LABA)
M.
Salbutamol metered dose inhaler (MDI)
N.
Short acting beta agonist (SABA) and leukotriene antagonist
You receive a paramedic call: they are bringing in a patient with asthma with unrecordable PEFR (peak expiratory flow rate), respiratory rate 32 breaths per minute and oxygen saturations of 89% on room air. What management would you instigate on arrival?
A.
Anti-histamine
B.
Anti-IgE therapy
C.
Beta blocker
D.
Check inhaler technique
E.
Epipen: Adrenaline 0.3mg IM
F.
High dose inhaled corticosteroid (ICS)
G.
High dose inhaled corticosteroid (ICS) + long-acting beta agonist (LABA) + leukotriene antagonist
H.
High dose inhaled corticosteroid (ICS) + long-acting beta agonist (LABA)
I.
High flow oxygen and Nebulised Salbutamol
J.
Low dose inhaled corticosteroid (ICS)
K.
Magnesium IV
L.
Medium dose inhaled corticosteroid (ICS) + long-acting beta agonist (LABA)
M.
Salbutamol metered dose inhaler (MDI)
N.
Short acting beta agonist (SABA) and leukotriene antagonist
Which of the following are contraindicated in asthma?
A.
Anti-histamine
B.
Anti-IgE therapy
C.
Beta blocker
D.
Check inhaler technique
E.
Epipen: Adrenaline 0.3mg IM
F.
High dose inhaled corticosteroid (ICS)
G.
High dose inhaled corticosteroid (ICS) + long-acting beta agonist (LABA) + leukotriene antagonist
H.
High dose inhaled corticosteroid (ICS) + long-acting beta agonist (LABA)
I.
High flow oxygen and Nebulised Salbutamol
J.
Low dose inhaled corticosteroid (ICS)
K.
Magnesium IV
L.
Medium dose inhaled corticosteroid (ICS) + long-acting beta agonist (LABA)
M.
Salbutamol metered dose inhaler (MDI)
N.
Short acting beta agonist (SABA) and leukotriene antagonist
A patient visits clinic and describes waking at night with asthma symptoms up to 4 nights a week. They have been prescribed Salbutamol as needed and low dose inhaled corticosteroid (ICS). What would be your initial management?
A.
Anti-histamine
B.
Anti-IgE therapy
C.
Beta blocker
D.
Check inhaler technique
E.
Epipen: Adrenaline 0.3mg IM
F.
High dose inhaled corticosteroid (ICS)
G.
High dose inhaled corticosteroid (ICS) + long-acting beta agonist (LABA) + leukotriene antagonist
H.
High dose inhaled corticosteroid (ICS) + long-acting beta agonist (LABA)
I.
High flow oxygen and Nebulised Salbutamol
J.
Low dose inhaled corticosteroid (ICS)
K.
Magnesium IV
L.
Medium dose inhaled corticosteroid (ICS) + long-acting beta agonist (LABA)
M.
Salbutamol metered dose inhaler (MDI)
N.
Short acting beta agonist (SABA) and leukotriene antagonist
Early signs of axillary and pubic hair can present in a healthy pre-pubescent girl as a result of hormones released from which organ?
A.
Adrenal cortex
B.
Adrenal medulla
C.
Anterior pituitary gland
D.
Hypothalamus
E.
Ovary
F.
Pancreas
G.
Parathyroid glands
H.
Posterior pituitary gland
I.
Testes
J.
Thyroid gland
A 46 X 0 karotype is associated with dyplasia of which organ?
A.
Adrenal cortex
B.
Adrenal medulla
C.
Anterior pituitary gland
D.
Hypothalamus
E.
Ovary
F.
Pancreas
G.
Parathyroid glands
H.
Posterior pituitary gland
I.
Testes
J.
Thyroid gland
Normal puberty in girls is initiated by pulsatile secretion from which organ?
A.
Adrenal cortex
B.
Adrenal medulla
C.
Anterior pituitary gland
D.
Hypothalamus
E.
Ovary
F.
Pancreas
G.
Parathyroid glands
H.
Posterior pituitary gland
I.
Testes
J.
Thyroid gland
Maternal diabetes can lead to foetal hypertrophy in which structure?
A.
Adrenal cortex
B.
Adrenal medulla
C.
Anterior pituitary gland
D.
Hypothalamus
E.
Ovary
F.
Pancreas
G.
Parathyroid glands
H.
Posterior pituitary gland
I.
Testes
J.
Thyroid gland
The commonest autoimmune endocrine disorder in the 2-9 year old age group is due to abnormal function of which structure?
A.
Adrenal cortex
B.
Adrenal medulla
C.
Anterior pituitary gland
D.
Hypothalamus
E.
Ovary
F.
Pancreas
G.
Parathyroid glands
H.
Posterior pituitary gland
I.
Testes
J.
Thyroid gland
The predictive value of a negative test (negative predictive value).
A.
FN / (FN+TN)
B.
FN / (TP+FN)
C.
FP / (FP+TN)
D.
FP / (TP+FP)
E.
TN / (TN+FP)
F.
TN / (TN+FN)
G.
(FP+FN) / (TP+FN+TN+FP)
H.
(TP+TN) / (TP+FN+TN+FP)
I.
TP / (TP+FN)
J.
TP / (TP+FP)
The predictive value of a positive test (positive predictive value).
A.
FN / (FN+TN)
B.
FN / (TP+FN)
C.
FP / (FP+TN)
D.
FP / (TP+FP)
E.
TN / (TN+FP)
F.
TN / (TN+FN)
G.
(FP+FN) / (TP+FN+TN+FP)
H.
(TP+TN) / (TP+FN+TN+FP)
I.
TP / (TP+FN)
J.
TP / (TP+FP)
The sensitivity of the test.
A.
FN / (FN+TN)
B.
FN / (TP+FN)
C.
FP / (FP+TN)
D.
FP / (TP+FP)
E.
TN / (TN+FP)
F.
TN / (TN+FN)
G.
(FP+FN) / (TP+FN+TN+FP)
H.
(TP+TN) / (TP+FN+TN+FP)
I.
TP / (TP+FN)
J.
TP / (TP+FP)
